Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4Z1 | Q86W10 | 10/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | SLC9A1 | P19634 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | CYP4F8 | P98187 | 1/20 | 0.38 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8491002 | 0.73 | CYP4Z1 (0.50) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL18833167 | 0.69 | CYP4Z1 (0.53) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL29518725 | 0.69 | CYP4Z1 (0.57) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL7243835 | 0.69 | POLB (0.55) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL5662069 | 0.69 | CYP4Z1 (0.57) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL16639135 | 0.69 | CYP4Z1 (0.55) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL14548209 | 0.68 | RAB9A (0.51) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 | |
| SCHEMBL1757403 | 0.66 | CYP4Z1 (0.50) | CYP4Z1CYP1A2SLC9A1POLBMAPK1 | |
| SCHEMBL27416345 | 0.66 | SLC9A1 (0.57) | SLC9A1ALDH1A1CYP2D6MAPTRAB9A | |
| SCHEMBL14679890 | 0.65 | CYP4Z1 (0.71) | CYP4Z1CYP1A2SLC9A1POLBCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1727807-B1 | ANTIOZONANT BASED FUNCTIONALIZED BENZOTRIAZOLE UV ABSORBERS AND THE PROCESS THEREOF | COUNCIL SCIENT IND RES (IN) | 2007-07-18 | — | — | EP | disclosed |
| US-7211675-B2 | Antiozonant based on functionalized benzotriazole UV absorbers and the process thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-05-01 | — | — | US | disclosed |
| EP-1727807-A1 | ANTIOZONANT BASED FUNCTIONALIZED BENZOTRIAZOLE UV ABSORBERS AND THE PROCESS THEREOF | Council of Scientific and Industrial Research (IN) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005066141-A1 | ANTIOZONANT BASED FUNCTIONALIZED BENZOTRIAZOLE UV ABSORBERS AND THE PROCESS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143584-A1 | Antiozonant based on functionalized benzotriazole UV absorbers and the process thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143584-A1 | Antiozonant based on functionalized benzotriazole UV absorbers and the process thereof | SULT1A1, AOX1, XDH | CYP4Z1 151/4885CYP1A2 29/4885SLC9A1 1655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.